Rare Disease. Commercial Precision. 23 Years Inside the Rooms Where These Decisions Are Made.

Brian Baldari is the founder and principal of Resilient Performance Group LLC, a life sciences strategic advisory practice serving biotech and biopharma organizations with pipeline-stage assets across rare disease, complement biology, renal, hematology, and specialty therapeutic areas.

He brings 23 years of direct commercial and medical affairs leadership inside the organizations now competing against his clients' programs. That is not a market research perspective.

That is insider knowledge deployed on behalf of the companies that need it most.

Brian Baldari's complete 23-year career record and therapeutic area experience is documented at brianbaldari-nj.com.

"I have been inside the organizations now competing against your asset. I was not an observer. I was the person responsible for the commercial strategy. That experience is now deployed on behalf of the companies that need it most."

The differentiator that defines Resilient Performance Group LLC is direct:

Brian Baldari has personal launch experience inside the organizations now competing against his current clients' programs in rare renal disease, complement biology, and adjacent therapeutic areas.

He built commercial strategies for those assets. He sat in the rooms where those positioning decisions were made. He knows exactly how those organizations think, plan, and execute — and that knowledge is now available to the companies on the other side of the table.

This is not a credential claim. It is a deliberate, publicly statable competitive advantage.

Resilient Performance Group LLC provides general management-level advisory across nine capability areas:

Rare Disease Commercial Strategy

— launch readiness, patient identification, market access, field force deployment, and KOL engagement for ultra-rare and rare disease pipeline assets.

Complement Biology Market Intelligence

— category dynamics, competitive positioning, and commercial differentiation for complement inhibitor programs.

Renal and Nephrology Launch Planning

— rare renal and ultra-rare nephrology commercialization, including IgA nephropathy, C3G, and complement-mediated renal disease.

Market Access and Payer Strategy

— payer landscape assessment, value dossier development, HEOR narrative, and access pathway planning for specialty and ultra-rare assets.

Medical Affairs Alignment

— MSL deployment strategy, medical communication planning, and clinical evidence gap analysis in support of pre-launch and launch-stage programs.

Pipeline Portfolio Optimization

— portfolio prioritization frameworks, indication sequencing, and lifecycle management strategy across multi-asset rare disease portfolios.

Global Launch Strategy

— international commercialization sequencing, ex-US market entry strategy, and global brand architecture for assets with multi-geography launch timelines.

Commercial Readiness Assessment

— structured evaluation of commercial readiness across people, process, and infrastructure for organizations approaching pivotal trial readouts.

Business Development and Licensing Support

— commercial diligence, market opportunity sizing, and deal framework support for in-licensing, out-licensing, and acquisition evaluations.

The leadership development philosophy that runs in parallel with this advisory practice is at brianbaldariresilexec.com.

14 Blockbuster Brands Launched · 23 Years Healthcare Leadership · Rare Renal · Complement Biology · Ophthalmology · Cardiometabolics · Hematology · Neuroscience · Women's Health · GLP-1

ABOUT THE ADVISOR

Brian Baldari — Pharm.D. | MBA | 23-Year Life Sciences Leader

Brian earned his Doctor of Pharmacy at Rutgers University and his MBA in Healthcare from George Washington University. He began his career as a Medical Science Liaison at Watson Pharmaceuticals, where he built his clinical foundation before transitioning into commercial leadership. Over the next two decades he rose through successive Director roles at Boehringer Ingelheim — where he held five consecutive Director-level positions across global pipeline marketing, managed markets, and HCP marketing — before ascending to Executive Director and then VP and Senior General Manager at Novartis, where he led a 250-person rare disease business unit and earned the Novartis President's Award as a Top 5 US Leader.

Today he leads Resilient Performance Group LLC from Brick Township, Ocean County, New Jersey — providing fractional general management advisory to biotech and biopharma organizations that need proven commercial leadership without full-time overhead

The full personal narrative behind this career is at brianbaldarinj.com.

Brian publishes weekly insights on executive leadership and advancement at The ResilExec® Blog.

The Skip-Level Relationship: How to Build Strategic Access to the Leaders Who Actually Control Your Promotion

The Skip-Level Relationship: How to Build Strategic Access to the Leaders Who Actually Control Your Promotion

Your manager advocates for you. But the leader who controls your promotion is one level above that. Here's how to build that relationship. ...more

Promotion Strategy

July 13, 2026undefined

The High Performer's Paradox: Why the Skills That Made You Exceptional Are the Same Ones Holding You Back

The High Performer's Paradox: Why the Skills That Made You Exceptional Are the Same Ones Holding You Back

For the first decade of your career, the system was honest with you. High performance produced advancement. Then something changed and nobody told you. Here is what actually happened and what to do ab... ...more

Promotion Strategy

July 12, 2026undefined

The 4 Currencies of Executive Influence: What You're Really Trading On

The 4 Currencies of Executive Influence: What You're Really Trading On

Positional authority doesn't scale at the executive level. Four currencies replace it. Here's what they are and how to build each one. ...more

Sponsorship & Visibility

July 08, 2026undefined

The advisor who has been on the other side of the table.

Fourteen brands launched. Three therapeutic areas where Brian's prior insider experience is now the strategic asset your program needs. The organizations competing against you built their strategies with people like Brian at the table. Now you can have that same perspective working for you.

The Full Career Record

23 years. 14 brands. Rare renal. Complement biology. The complete professional credential documentation.

Brian Baldari's full credential record

brianbaldari-nj.com

Executive Coaching

The same leadership system Brian built for himself — now deployed for Directors and VPs in healthcare and enterprise IT.

ResilExec® executive coaching for healthcare leaders → resilexec.com

The Full Story

Career, character, athletic identity, community roots, and the purpose that connects it all.

Brian Baldari's complete professional and personal narrative → brianbaldarinj.com

BRIAN BALDARI

Pharm.D. | MBA | Life Sciences Leader

Founder and Principal, Resilient Performance Group LLC

Founder, ResilExec® Coaching

"My purpose is to improve the health and wellbeing of my global family — by advancing therapies that address chronic, life-threatening, and rare diseases, by developing the leaders who execute those missions, and by coaching individuals to perform at the highest level of their human potential."

© 2026 Resilient Performance Group LLC · All Rights Reserved · resilexec.com